Richard B. Davis, Associate

Publications and Presentations

Customer in pharmacy holding medicine bottle. Woman reading the label text about medical information or side effects in drug store. Patient shopping pills for migraine or flu.
Brenda M. Maloney ShaferBrenda M. Maloney Shafer
The End of a Wild Year for 340B: HHS Issues Advisory Opinion and New GAO Report Sheds Light on HRSA’s Enforcement PullbackTo Be Or Not To 340BBrenda M. Maloney Shafer, Richard B. Davis, David M. Blank2020 was a tumultuous year for virtually everyone and everything, and the 340B Program was no exception. As we outlined in previous articles, many drug manufacturers have decided that the Health Resources and Services Administration’s Office of Pharmacy Affairs (“HRSA... Read More
Presentation "Multistate Pharmacy Jurisprudence Review" Medical College of Wisconsin School of Pharmacy By: Roger N. Morris, Richard B. Davis
"The 340B Drug Pricing Program Year in Review: What's Smoke and What's Fire in a Changing Landscape" Quarles & Brady Pharmacy Law Symposium